| Sarah Elizabeth Hussung, MS CFY SLP | |
|
120 Carriage Way, Hopkinsville, KY 42240 | |
| (270) 791-9805 | |
| Not Available |
| Full Name | Sarah Elizabeth Hussung |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 120 Carriage Way, Hopkinsville, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770809840 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 245162 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Elizabeth Hussung, MS CFY SLP 120 Carriage Way, Hopkinsville, KY 42240-7939 Ph: (270) 791-9805 | Sarah Elizabeth Hussung, MS CFY SLP 120 Carriage Way, Hopkinsville, KY 42240 Ph: (270) 791-9805 |
News Archive
Michelle Hastings, PhD, Assistant Professor in the Department of Cell Biology and Anatomy, in the Chicago Medical School of Rosalind Franklin University of Medicine and Science, has been awarded a five-year $1.68 million grant from the National Institutes of Health to support her research aimed at investigating treatments for the fatal children's disease, Spinal Muscular Atrophy (SMA).
Researchers have discovered that a new anti-rejection drug that is gentler on the kidneys after liver transplant also reduces weight gain, which is common after surgery and can lead to serious complications for transplant patients.
Accuray Incorporated, a global leader in the field of radiosurgery, announced today that the company was awarded a $1 million Small Business Innovation Research (SBIR) grant by the U.S. Government to be used toward further development of a high-energy X-ray source for Homeland Security applications.
Researchers at Inserm, led by Claude Gronfier (Inserm Unit 846: Stem Cell and Brain Institute), have, for the first time, conducted a study under real conditions on the body clocks of members of the international polar research station Concordia.
Takeda Pharmaceutical Company Limited (Takeda) announced today that Takeda Global Research & Development Center, Inc., U.S., submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for azilsartan medoxomil (development code: TAK-491), an angiotensin II receptor blocker (ARB) under investigation for the treatment of hypertension. Discovered by Takeda, azilsartan medoxomil is designed to lower blood pressure by blocking the action of a vasopressor hormone, angiotensin II.
› Verified 9 days ago
Inspira Therapy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1110 South Main Street, Suite B, Hopkinsville, KY 42240 Phone: 270-889-3518 | |
Mrs. Caroline C Smith, M.S., CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1717 High St, Suite 2c, Hopkinsville, KY 42240 Phone: 270-885-7023 Fax: 270-881-3983 | |
Mrs. Lugene Sadler, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1100 S Main St, Hopkinsville, KY 42240 Phone: 270-707-3454 | |
The Speech Spot Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1910 S Virginia St, Ste 103, Hopkinsville, KY 42240 Phone: 270-707-3454 Fax: 270-220-0249 | |
Mrs. Martha Pigage, M.S. CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1910 S Virginia St Ste 103, Hopkinsville, KY 42240 Phone: 270-707-3454 | |
Dorothy Garnett, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1595 John Rives Rd, Hopkinsville, KY 42240 Phone: 931-905-5729 | |
Ms. Brittany Madison Helton, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 500 Clinic Dr, Hopkinsville, KY 42240 Phone: 270-707-3365 Fax: 270-707-3366 |